Elevance Health shares are trading lower following a Q3 earnings miss and soft FY24 guidance.
Portfolio Pulse from Benzinga Newsdesk
Elevance Health's shares are declining due to a Q3 earnings miss and weak FY24 guidance.
October 17, 2024 | 10:50 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Elevance Health's shares are trading lower after the company reported a Q3 earnings miss and provided soft guidance for FY24.
The company's Q3 earnings miss indicates underperformance, which typically leads to a negative market reaction. Additionally, the soft FY24 guidance suggests potential challenges ahead, further contributing to the stock's decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100